MK-@ caused a dose-dependent decrease in absolute neutrophil count ( ANC ) and reduced inflammatory biomarkers matrix metallopeptidase-@ and myeloperoxidase in plasma and sputum ; ANC lower than @ ( @ ) / L led to discontinuations with higher doses of MK-@ ( @ % in the MK-@ @-mg group vs. @ % in placebo ) .